SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 2188711

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2188711

Endometriosis Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments & Equipment; Reagents, Consumables, Kits & Assays; Software & Services), By Technology, By End-use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Endometriosis Diagnostics Market Summary

The global endometriosis diagnostics market size was valued at USD 454.8 million in 2025 and is projected to grow from USD 491.2 million in 2026 to USD 886.5 million by 2033, at a CAGR of 8.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 39.0% in 2025. Industry growth is primarily driven by the increasing demand for earlier and less-invasive endometriosis diagnosis, expanding adoption of advanced imaging and biomarker-based testing, and continued development of novel molecular diagnostic approaches.

Global Endometriosis Diagnostics Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global endometriosis diagnostics market report on the basis of product, technology, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments & Equipment
  • Reagents, Consumables, Kits & Assays
  • Software & Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostic Imaging
  • Laparoscopic Visualization
  • Biomarker & Molecular Diagnostics
  • Other Technologies
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Gynecology Clinics
  • Fertility & IVF Centers
  • Diagnostic & Pathology Laboratories
  • Other End Users
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Product Code: GVR-4-68041-062-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Technology Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Global Endometriosis Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing demand for early and less-invasive endometriosis diagnosis
      • 3.2.1.2. Rising prevalence and clinical burden of endometriosis
      • 3.2.1.3. Technological advancements in imaging, biomarker, and molecular diagnostics
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Limited Diagnostic Accuracy and Clinical Validation Challenges
      • 3.2.2.2. High Cost and Limited Accessibility of Advanced Diagnostic Procedures
    • 3.2.3. Market opportunity analysis
  • 3.3. Global Endometriosis Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Global Endometriosis Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Endometriosis Diagnostics Market Product Movement Analysis
  • 4.3. Global Endometriosis Diagnostics Market Size & Trend Analysis by Product, 2021 to 2033 (USD Million)
  • 4.4. Instruments & Equipment
    • 4.4.1. Instruments & Equipment market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Reagents, Consumables, Kits & Assays
    • 4.5.1. Reagents, Consumables, Kits & Assays market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Software & Services
    • 4.6.1. Software & Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Global Endometriosis Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Endometriosis Diagnostics Market Technology Movement Analysis
  • 5.3. Global Endometriosis Diagnostics Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Diagnostic Imaging
    • 5.4.1. Diagnostic Imaging market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Laparoscopic Visualization
    • 5.5.1. Laparoscopic Visualization market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Biomarker & Molecular Diagnostics
    • 5.6.1. Biomarker & Molecular Diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Other Technologies
    • 5.7.1. Other Technologies market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Global Endometriosis Diagnostics Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Endometriosis Diagnostics Market End Use Movement Analysis
    • 6.2.1. Global Endometriosis Diagnostics Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4. Gynecology Clinics
    • 6.4.1. Gynecology Clinics market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Fertility & IVF Centers
    • 6.5.1. Fertility & IVF Centers market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Diagnostic & Pathology Laboratories
    • 6.6.1. Diagnostic & Pathology Laboratories market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Other End Users
    • 6.7.1. Other End Users market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Endometriosis Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2025
  • 8.4. List of Key Certification Providers/Scheme Owners
  • 8.5. Company Profiles/Listing
    • 8.5.1. GE HealthCare
      • 8.5.1.1. Company overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. Koninklijke Philips N.V.
      • 8.5.2.1. Company overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Siemens Healthineers AG
      • 8.5.3.1. Company overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. Canon Inc.
      • 8.5.4.1. Company overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. FUJIFILM Holdings Corporation
      • 8.5.5.1. Company overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. Olympus Corporation
      • 8.5.6.1. Company overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. KARL STORZ SE & Co. KG
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. EndoSure, Inc.
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Stryker Corporation
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Samsung Medison Co., Ltd.
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Esaote S.p.A.
      • 8.5.11.1. Company overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 8.5.12.1. Company overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. B. Braun SE
      • 8.5.13.1. Company overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product benchmarking
      • 8.5.13.4. Strategic initiatives
Product Code: GVR-4-68041-062-9

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 5 Global Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 6 North America Endometriosis Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 8 North America Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 9 North America Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 10 U.S. Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 11 U.S. Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 12 U.S. Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 13 Canada Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 14 Canada Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 15 Canada Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 17 Mexico Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 18 Mexico Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe Endometriosis Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 21 Europe Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 22 Europe Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 23 UK Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 24 UK Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 25 UK Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 26 Germany Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 27 Germany Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 28 Germany Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 29 France Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 30 France Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 31 France Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 32 Italy Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 33 Italy Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 34 Italy Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 35 Spain Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 36 Spain Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 37 Spain Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 38 Denmark Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 39 Denmark Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 40 Denmark Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 41 Sweden Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 42 Sweden Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 43 Sweden Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 44 Norway Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 45 Norway Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 46 Norway Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Endometriosis Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 51 Japan Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 52 Japan Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 53 Japan Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 54 China Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 55 China Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 56 China Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 57 India Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 58 India Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 59 India Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 60 Australia Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 61 Australia Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 62 Australia Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 63 South Korea Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 64 South Korea Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 65 South Korea Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 66 Thailand Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 67 Thailand Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 68 Thailand Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 69 Latin America Endometriosis Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 71 Latin America Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 72 Latin America Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 73 Brazil Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 74 Brazil Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 75 Brazil Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 76 Argentina Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 77 Argentina Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 78 Argentina Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 79 MEA Endometriosis Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 81 MEA Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 82 MEA Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 83 South Africa Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 84 South Africa Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 85 South Africa Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 89 UAE Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 90 UAE Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 91 UAE Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Endometriosis Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Endometriosis Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Endometriosis Diagnostics Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Endometriosis Diagnostics Market: Market outlook
  • Fig. 9 Endometriosis Diagnostics Market: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Endometriosis diagnostics market driver impact
  • Fig. 15 Endometriosis diagnostics market restraint impact
  • Fig. 16 Endometriosis diagnostics market strategic initiatives analysis
  • Fig. 17 Endometriosis diagnostics market: Product movement analysis
  • Fig. 18 Endometriosis diagnostics market: Product outlook and key takeaways
  • Fig. 19 Reagents, Consumables, Kits & Assays & systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Instruments & Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Software & Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Endometriosis diagnostics market: Technology movement analysis
  • Fig. 23 Endometriosis diagnostics market: Technology outlook and key takeaways
  • Fig. 24 Diagnostic Imaging market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Laparoscopic Visualization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Biomarker & Molecular Diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Other Technologies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Endometriosis diagnostics market: End Use movement analysis
  • Fig. 29 Endometriosis diagnostics market: End Use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Gynecology Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Fertility & IVF Centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Diagnostic & Pathology Laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Other End Users market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Global Endometriosis diagnostics market: Regional movement analysis
  • Fig. 36 Global Endometriosis diagnostics market: Regional outlook and key takeaways
  • Fig. 37 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!